Clinical Trials Browser

Terminated × Endometrial Neoplasms × TIC10 compound × Clear all

NCT03099499 2024-12-24

Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer

Phase 2 Terminated

Endometrial Neoplasms